JAZZ technical analysis
JAZZ Technical Analysis
Analysis date
July 17, 2026
Market
NasdaqGS (USD)
Daily cutoff
July 16, 2026
Reliability
Passed
Informational use only. This page is not investment advice.
Data verification
JAZZ Data Verification
Cross-validating the latest completed daily bar across independent sources.
- Symbol
- JAZZ
- Market
- NasdaqGS
- Currency
- USD (US Dollar)
- Latest completed bar
- July 16, 2026
No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.
| Source | Latest Close | Date | Difference | Status |
|---|---|---|---|---|
| Yahoo Finance Chart API (primary) | 243.82 | July 16, 2026 | - | Verified |
| Finviz (independent) | 243.82 | July 16, 2026 (previous close) | 0.00% | Verified |
Bottom line
JAZZ Technical Analysis Summary
JAZZ (Jazz Pharmaceuticals) shows a strongly bullish technical structure across both daily and weekly timeframes. At 243.82, price is above all key moving averages on both the daily and weekly charts, confirming broad-based upward momentum. The daily RSI14 at 64.79 indicates bullish momentum without reaching overbought extremes. The daily MACD is positive with the MACD line above the signal line and a rising histogram, supporting the continuation of the uptrend. The weekly MACD is also positive with the MACD line above the signal line, confirming alignment between short-term and intermediate-term momentum. Key support rests at 221.58 (20-day low) and 209.49 (20-week low), while resistance sits at 248.00 (estimated 52-week high area) and the psychological 250 level. A sustained move above 250 would signal continued strength; a breakdown below 222 would suggest a bearish shift.
Multi-timeframe dashboard
Multi-Timeframe Technical Dashboard
Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.
Daily (July 16, 2026)
- Trend
- Bullish. Price at 243.82 is above SMA20 (234.51, +3.97%), SMA50 (226.84, +7.49%), and SMA200 (194.60, +25.30%). All three key SMAs are in bullish alignment with SMA20 above SMA50 above SMA200, a classic sign of a strong uptrend. The SMA200 continues to slope upward, reflecting sustained long-term appreciation.
- Momentum
- Bullish. RSI14 at 64.79 is above the 50 midline but below the 70 overbought threshold, indicating healthy bullish momentum without exhaustion. MACD line at 5.12 is above the signal line at 3.86, and the histogram at 1.26 is positive and rising, confirming accelerating upside momentum.
- Volatility
- Moderate. ATR14 at 6.84 (2.81% of price) suggests average daily movement of about 2.8%. Bollinger Bands (219.45 to 251.67) show price near the upper band, reflecting the recent upward bias. Band width is moderate, indicating normal volatility conditions for a biotech stock.
- Volume
- Slightly below average. Latest volume of 812,400 is 89.3% of the 20-period average (909,680), indicating slightly reduced participation though not significantly different from normal.
Assessment
The daily timeframe presents a clearly bullish picture. Price is well above all major moving averages with bullish alignment, RSI is in a healthy bullish range without being overbought, and the MACD histogram is rising. The only point of caution is the price position near the upper Bollinger Band, which can sometimes precede short-term pullbacks, but the overall structure supports the continuation of the uptrend. A sustained move above 248 would confirm the next leg higher.
Weekly (July 13, 2026 week)
- Trend
- Bullish. Price at 243.82 is above SMA20 (220.34), SMA50 (204.15), and SMA200 (144.68). All three weekly SMAs are in a textbook bullish ascending order with SMA20 above SMA50 above SMA200. The SMA200 slope is steeply upward, reflecting the powerful long-term uptrend that has seen the stock more than double over the past year.
- Momentum
- Bullish. RSI14 at 65.43 is in bullish territory, confirming strong intermediate-term momentum. MACD line at 12.68 is above the signal line at 10.54, and the histogram at 2.14 is positive and stable, indicating sustained upward momentum on the weekly timeframe.
- Volatility
- Moderate. ATR14 at 13.47 (5.52% of price) reflects typical weekly ranges for a mid-cap biotech stock in an uptrend. Bollinger Bands (190.28 to 263.10) are wide but not unusually so, consistent with the strong trending behavior.
- Volume
- Near average. Weekly volume of 4,210,300 is 97.6% of the 20-week average (4,313,940), indicating that the uptrend is supported by normal participation levels.
Assessment
The weekly chart confirms a powerful and sustained uptrend. Price is well above all major moving averages with textbook bullish alignment. The MACD is positive and the histogram is stable, indicating momentum is being maintained rather than fading. The 52-week position near the high end suggests the trend is strong but also means the stock has already appreciated significantly. The weekly structure supports the bullish thesis as long as price holds above the SMA20 at 220.34.
Key indicators
JAZZ Key Technical Indicators
RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.
| Indicator | Daily | Weekly |
|---|---|---|
| RSI (14) | 64.79 | 65.43 |
| MACD (12, 26, 9) | 5.12 / 3.86 / 1.26 | 12.68 / 10.54 / 2.14 |
| ATR (14) | 6.84 (2.81%) | 13.47 (5.52%) |
| Bollinger Bands (20, 2) | 219.45 - 251.67 | 190.28 - 263.10 |
| SMA (20) | 234.51 | 220.34 |
| SMA (50) | 226.84 | 204.15 |
| SMA (200) | 194.60 | 144.68 |
Price structure
JAZZ Price Structure and Returns
Price performance across multiple lookback periods and 52-week position.
| Metric | Daily | Weekly |
|---|---|---|
| Current Price | 243.82 | 243.82 |
| 1-Period Return | +0.85% | +1.62% |
| 5-Period Return | +3.21% | +4.85% |
| 20-Period Return | +8.47% | +15.32% |
| 60-Period Return | +14.68% | +38.91% |
| 252-Period Return | +85.40% | +126.50% |
| 52-Week Low | 107.68 | 107.68 |
| 52-Week High | 248.00 | 248.00 |
| 52-Week Position | 97.50% | 95.30% |
Key levels
JAZZ Support and Resistance Levels
Key price levels based on recent swing highs and lows across daily and weekly timeframes.
| Level | Daily | Weekly |
|---|---|---|
| 20-Period High | 248.00 | 248.00 |
| 20-Period Low | 221.58 | 209.49 |
| 60-Period High | 248.00 | 248.00 |
| 60-Period Low | 202.35 | 175.80 |
Scenarios
JAZZ Technical Scenarios
Conditions, invalidation triggers, and what to watch for each scenario.
Bullish
Trigger
Price breaks above 248.00 (estimated 52-week high) and holds above the 250 psychological level.
Invalidation
Price falls below the 20-day low of 221.58.
What to watch
Sustained close above SMA20 (234.51) followed by increasing volume through the 248 resistance area.
Range-Bound
Trigger
Price continues to oscillate between 221.58 support and 248.00-250.00 resistance zone.
Invalidation
A decisive break of either boundary with above-average volume.
What to watch
RSI staying between 55 and 70; the daily MACD histogram remaining positive but not accelerating.
Bearish
Trigger
Price breaks below 221.58 (20-day low) and fails to reclaim SMA20.
Invalidation
Price reclaims SMA20 (234.51) and holds above it.
What to watch
Sustained closes below SMA50 (226.84); the MACD histogram turning negative; RSI dropping below 50.
Methodology
Methodology and Limitations
This technical analysis uses adjusted closing prices from Yahoo Finance (primary) and Finviz (independent cross-validation). The daily analysis covers approximately 2 years (500 completed bars) ending July 16, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 13, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.
Frequently Asked Questions
This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 16, 2026, weekly July 13, 2026 week. Generated July 17, 2026.
Related Tools
AI Chart Analyzer
Upload a TradingView chart screenshot and get instant AI-powered technical analysis. Identify patterns, support and resistance, and key levels.
Support and Resistance Calculator
Calculate key support and resistance levels for any stock. Identify potential price zones where reversals or breakouts may occur.
RSI Calculator
Calculate the Relative Strength Index for any stock. Determine overbought and oversold conditions with customizable periods.